Ironwood and Allergan Receive Notices of Allowance for Patent Applications Covering 72 mcg Dose of LINZESS® (linaclotide)
https://investor.ironwoodpharma.com/press-releases/press-release-details/2020/Ironwood-and-Allergan-Receive-Notices-of-Allowance-for-Patent-Applications-Covering-72-mcg-Dose-of-LINZESS-linaclotide/default.aspx
Ironwood Pharmaceuticals to Host First Quarter 2020 Investor Update Call
https://investor.ironwoodpharma.com/press-releases/press-release-details/2020/Ironwood-Pharmaceuticals-to-Host-First-Quarter-2020-Investor-Update-Call/default.aspx
Ironwood Pharmaceuticals to Host First Quarter 2020 Investor Update Call
https://investor.ironwoodpharma.com/press-releases/press-release-details/2020/Ironwood-Pharmaceuticals-to-Host-First-Quarter-2020-Investor-Update-Call/default.aspx
Ironwood Pharmaceuticals Provides Update on Impact of COVID-19
https://investor.ironwoodpharma.com/press-releases/press-release-details/2020/Ironwood-Pharmaceuticals-Provides-Update-on-Impact-of-COVID-19/default.aspx
Ironwood Pharmaceuticals Provides Update on Impact of COVID-19
https://investor.ironwoodpharma.com/press-releases/press-release-details/2020/Ironwood-Pharmaceuticals-Provides-Update-on-Impact-of-COVID-19/default.aspx
A message to our healthcare providers, patients and other partners during COVID-19
https://investor.ironwoodpharma.com/press-releases/press-release-details/2020/COVID-19-IRWD-Public-Letter/default.aspx
A message to our healthcare providers, patients and other partners during COVID-19
https://investor.ironwoodpharma.com/press-releases/press-release-details/2020/COVID-19-IRWD-Public-Letter/default.aspx
Ironwood Pharmaceuticals Announces Publication of Positive IW-3718 Phase IIb Data in Gastroenterology
https://investor.ironwoodpharma.com/press-releases/press-release-details/2020/Ironwood-Pharmaceuticals-Announces-Publication-of-Positive-IW-3718-Phase-IIb-Data-in-Gastroenterology/default.aspx
Ironwood Pharmaceuticals Announces Publication of Positive IW-3718 Phase IIb Data in Gastroenterology
https://investor.ironwoodpharma.com/press-releases/press-release-details/2020/Ironwood-Pharmaceuticals-Announces-Publication-of-Positive-IW-3718-Phase-IIb-Data-in-Gastroenterology/default.aspx
Ironwood Pharmaceuticals to Present at Upcoming March Investor Conferences
https://investor.ironwoodpharma.com/press-releases/press-release-details/2020/Ironwood-Pharmaceuticals-to-Present-at-Upcoming-March-Investor-Conferences/default.aspx